Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05289856
Title Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Johannes Gutenberg University Mainz
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.